Insider Transaction Report for Katherine Murray

Katherine Murray, a director at Core Laboratories Inc. /DE/, reported a series of transactions on April 1, 2026. In a non-derivative transaction, 8,069 shares of Common Stock were acquired, bringing the total post-transaction shares to 29,290. Additionally, two derivative transactions involving Restricted Shares were reported. First, 7,895 Restricted Shares were acquired, with a post-transaction ownership of 7,895 shares. Subsequently, 8,069 Restricted Shares were disposed of, resulting in zero shares owned. These Restricted Shares are linked to the Common Stock. Footnote 1 indicates that the Restricted Shares vest on April 1, 2027, subject to a one-year vesting period and potential deferral under Treasury Regulation 1.409A-2, with distribution occurring post-separation from the Board. Footnote 2 clarifies that the disposed Restricted Shares vested at the end of a one-year period on April 1, 2026.